• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏病与代谢性脂肪变性之间的相互作用:当代视角

Interplay between Heart Disease and Metabolic Steatosis: A Contemporary Perspective.

作者信息

Ramadan Mohammad Said, Russo Vincenzo, Nigro Gerardo, Durante-Mangoni Emanuele, Zampino Rosa

机构信息

Department of Precision Medicine, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.

Department of Translational Medical Sciences, AORN Ospedali dei Colli-Monaldi Hospital, 80131 Naples, Italy.

出版信息

J Clin Med. 2021 Apr 8;10(8):1569. doi: 10.3390/jcm10081569.

DOI:10.3390/jcm10081569
PMID:33917867
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8068259/
Abstract

The liver-heart axis is a growing field of interest owing to rising evidence of complex bidirectional interplay between the two organs. Recent data suggest non-alcoholic fatty liver disease (NAFLD) has a significant, independent association with a wide spectrum of structural and functional cardiac diseases, and seems to worsen cardiovascular disease (CVD) prognosis. Conversely, the effect of cardiac disease on NAFLD is not well studied and data are mostly limited to cardiogenic liver disease. We believe it is important to further investigate the heart-liver relationship because of the tremendous global health and economic burden the two diseases pose, and the impact of such investigations on clinical decision making and management guidelines for both diseases. In this review, we summarize the current knowledge on NAFLD diagnosis, its systemic manifestations, and associations with CVD. More specifically, we review the pathophysiological mechanisms that govern the interplay between NAFLD and CVD and evaluate the relationship between different CVD treatments and NAFLD progression.

摘要

由于越来越多的证据表明肝脏和心脏之间存在复杂的双向相互作用,肝心轴成为一个日益受到关注的领域。最近的数据表明,非酒精性脂肪性肝病(NAFLD)与多种结构和功能性心脏病存在显著的独立关联,并且似乎会恶化心血管疾病(CVD)的预后。相反,心脏病对NAFLD的影响尚未得到充分研究,数据大多局限于心源性肝病。鉴于这两种疾病给全球健康和经济带来的巨大负担,以及此类研究对这两种疾病的临床决策和管理指南的影响,我们认为进一步研究心-肝关系非常重要。在这篇综述中,我们总结了目前关于NAFLD诊断、其全身表现以及与CVD关联的知识。更具体地说,我们回顾了支配NAFLD与CVD之间相互作用的病理生理机制,并评估了不同CVD治疗方法与NAFLD进展之间的关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/244b/8068259/2bfcf8e9d4ec/jcm-10-01569-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/244b/8068259/6fe1c4cbf8e7/jcm-10-01569-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/244b/8068259/2bfcf8e9d4ec/jcm-10-01569-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/244b/8068259/6fe1c4cbf8e7/jcm-10-01569-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/244b/8068259/2bfcf8e9d4ec/jcm-10-01569-g002.jpg

相似文献

1
Interplay between Heart Disease and Metabolic Steatosis: A Contemporary Perspective.心脏病与代谢性脂肪变性之间的相互作用:当代视角
J Clin Med. 2021 Apr 8;10(8):1569. doi: 10.3390/jcm10081569.
2
[Cardiovascular Risk in Patients with Non-alcoholic Fatty Liver Disease].[非酒精性脂肪性肝病患者的心血管风险]
Korean J Gastroenterol. 2017 Jun 25;69(6):333-340. doi: 10.4166/kjg.2017.69.6.333.
3
Cardiovascular Risk in Fatty Liver Disease: The Liver-Heart Axis-Literature Review.脂肪性肝病中的心血管风险:肝-心轴——文献综述
Front Med (Lausanne). 2019 Sep 13;6:202. doi: 10.3389/fmed.2019.00202. eCollection 2019.
4
Hospital admission with non-alcoholic fatty liver disease is associated with increased all-cause mortality independent of cardiovascular risk factors.非酒精性脂肪性肝病患者住院与全因死亡率增加相关,与心血管危险因素无关。
PLoS One. 2020 Oct 27;15(10):e0241357. doi: 10.1371/journal.pone.0241357. eCollection 2020.
5
Non-alcoholic fatty liver disease: An overview of risk factors, pathophysiological mechanisms, diagnostic procedures, and therapeutic interventions.非酒精性脂肪性肝病:风险因素、病理生理机制、诊断程序和治疗干预的概述。
Life Sci. 2021 Apr 15;271:119220. doi: 10.1016/j.lfs.2021.119220. Epub 2021 Feb 13.
6
Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications.非酒精性脂肪性肝病与心血管风险:病理生理机制及意义。
J Hepatol. 2016 Aug;65(2):425-43. doi: 10.1016/j.jhep.2016.04.005. Epub 2016 Jun 1.
7
Association between non-alcoholic fatty liver disease and cardiovascular disease: a first message should pass.非酒精性脂肪性肝病与心血管疾病之间的关联:首要信息应当传达。
Am J Gastroenterol. 2008 Dec;103(12):3036-8. doi: 10.1111/j.1572-0241.2008.02196.x. Epub 2008 Oct 1.
8
The association of non-alcoholic fatty liver disease and atrial fibrillation: a review.非酒精性脂肪性肝病与心房颤动的相关性:综述。
Ann Med. 2018 Aug;50(5):371-380. doi: 10.1080/07853890.2018.1492147. Epub 2018 Jul 24.
9
Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update.非酒精性脂肪性肝病组织学谱中的心血管风险及临床表现:最新进展
World J Gastroenterol. 2015 Jun 14;21(22):6820-34. doi: 10.3748/wjg.v21.i22.6820.
10
NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications.非酒精性脂肪性肝病与心血管疾病风险增加:临床关联、病理生理机制及药理学意义
Gut. 2020 Sep;69(9):1691-1705. doi: 10.1136/gutjnl-2020-320622. Epub 2020 Apr 22.

引用本文的文献

1
Shared genetic architecture and causal relationship between liver and heart disease.肝脏疾病和心脏疾病之间的共同遗传结构及因果关系。
iScience. 2024 Mar 6;27(4):109431. doi: 10.1016/j.isci.2024.109431. eCollection 2024 Apr 19.
2
Cardiovascular Outcomes Among Persons with HIV and Nonalcoholic Fatty Liver Disease.感染艾滋病毒且患有非酒精性脂肪性肝病者的心血管结局
AIDS. 2023 Jul;37(8):1329-1331. doi: 10.1097/QAD.0000000000003562.
3
Cardiovascular Risk in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals.接受直接抗病毒药物治疗的慢性丙型肝炎患者的心血管风险

本文引用的文献

1
The effects of glucagon-like peptide-1 receptor agonists on glycemic control and anthropometric profiles among diabetic patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.胰高血糖素样肽-1 受体激动剂对非酒精性脂肪性肝病糖尿病患者血糖控制和人体测量特征的影响:系统评价和随机对照试验的荟萃分析。
Eur J Pharmacol. 2021 Feb 15;893:173823. doi: 10.1016/j.ejphar.2020.173823. Epub 2020 Dec 19.
2
Relationship between non-alcoholic fatty liver disease and coronary heart disease.非酒精性脂肪性肝病与冠心病之间的关系。
World J Clin Cases. 2020 Oct 26;8(20):4688-4699. doi: 10.12998/wjcc.v8.i20.4688.
3
J Clin Med. 2022 Sep 29;11(19):5781. doi: 10.3390/jcm11195781.
4
Metabolic Remodeling with Hepatosteatosis Induced Vascular Oxidative Stress in Hepatic ERK2 Deficiency Mice with High Fat Diets.高脂饮食诱导的肝 ERK2 缺陷小鼠肝脂肪变性的代谢重塑与血管氧化应激
Int J Mol Sci. 2022 Jul 31;23(15):8521. doi: 10.3390/ijms23158521.
Significance of MR/OPN/HMGB1 axis in NAFLD-associated hepatic fibrogenesis.
MR/OPN/HMGB1 轴在非酒精性脂肪性肝病相关肝纤维化中的意义。
Life Sci. 2021 Jan 1;264:118619. doi: 10.1016/j.lfs.2020.118619. Epub 2020 Oct 20.
4
Lipoprotein and Metabolic Profiles Indicate Similar Cardiovascular Risk of Liver Steatosis and NASH.脂代谢与代谢特征提示肝脂肪变性和 NASH 具有相似的心血管风险。
Digestion. 2021;102(5):671-681. doi: 10.1159/000510600. Epub 2020 Oct 20.
5
The efficacy of glucagon-like peptide 1 receptor agonists in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials.胰高血糖素样肽 1 受体激动剂在非酒精性脂肪性肝病患者中的疗效:一项随机对照试验的系统评价和荟萃分析。
Rev Esp Enferm Dig. 2020 Aug;112(8):627-635. doi: 10.17235/reed.2020.6392/2019.
6
NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications.非酒精性脂肪性肝病与心血管疾病风险增加:临床关联、病理生理机制及药理学意义
Gut. 2020 Sep;69(9):1691-1705. doi: 10.1136/gutjnl-2020-320622. Epub 2020 Apr 22.
7
Aspirin Improves Nonalcoholic Fatty Liver Disease and Atherosclerosis through Regulation of the PPAR-AMPK-PGC-1 Pathway in Dyslipidemic Conditions.阿司匹林通过调节脂代谢紊乱条件下的 PPAR-AMPK-PGC-1 通路改善非酒精性脂肪性肝病和动脉粥样硬化。
Biomed Res Int. 2020 Mar 19;2020:7806860. doi: 10.1155/2020/7806860. eCollection 2020.
8
Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders.肠道微生物群与人类非酒精性脂肪性肝病:从代谢紊乱中解析微生物特征。
Nat Rev Gastroenterol Hepatol. 2020 May;17(5):279-297. doi: 10.1038/s41575-020-0269-9. Epub 2020 Mar 9.
9
Relationship between Heart Disease and Liver Disease: A Two-Way Street.心脏病与肝病的关系:双向影响。
Cells. 2020 Feb 28;9(3):567. doi: 10.3390/cells9030567.
10
MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease.MAFLD:代谢相关脂肪性肝病的共识驱动命名建议。
Gastroenterology. 2020 May;158(7):1999-2014.e1. doi: 10.1053/j.gastro.2019.11.312. Epub 2020 Feb 8.